An artificial heart or stopping treatments, the doctors' dilemma
Doctors face a critical decision regarding whether to pursue an artificial heart for a child waiting for a transplant or to halt treatments due to deteriorating conditions.
The Carmat company liquidated, a new step for the artificial heart specialist
French company Carmat, which had been under judicial recovery since July, is being liquidated and will be succeeded by a new private entity taking over its activity of developing artificial hearts.